People: Nordion Inc (NDN.TO)

NDN.TO on Toronto Stock Exchange

7.48CAD
17 May 2013
Price Change (% chg)

$0.12 (+1.63%)
Prev Close
$7.36
Open
$7.37
Day's High
$7.51
Day's Low
$7.36
Volume
15,860
Avg. Vol
66,232
52-wk High
$10.86
52-wk Low
$5.38

Search Stocks

Summary

Name Age Since Current Position

William Anderson

 64 2010 Non-Executive Independent Chairman of the Board

Steven West

 57 2010 President, Chief Executive Officer, Non-Independent Director

G. Peter Dans

 2010 Chief Financial Officer

Grant Gardiner

 2013 Senior Vice President, General Counsel, Corporate Secretary

Christopher Ashwood

 2010 Senior Vice President - Corporate Services

Jill Chitra

 2010 Senior Vice President - Quality and Regulatory Affairs

Tamra Benjamin

 2010 Vice President - Public Affairs

Tom Burnett

 2012 General Manager - Medical Isotopes

Scott McIntosh

 2012 Chief Operating Officer - Specialty Isotopes

Jeffrey Brown

 51 2012 Independent Director

William Dempsey

 61 2008 Independent Director

Mary Mogford

 68 1998 Independent Director

Sean Murphy

 60 2011 Independent Director

Kenneth Newport

 47 2010 Independent Director

Adeoye Olukotun

 67 2010 Independent Director

Janet Woodruff

 55 2011 Independent Director

Ana Raman

 Director - Investor Relations
» Insider Trading

Biographies

Name Description

William Anderson

 Mr. William D. Anderson is Non-Executive Independent Chairman of the Board of Nordion Inc. Mr. Anderson, a Chartered Accountant, is a Corporate Director, having retired in 2005 after serving 14 years with BCE Inc. (a global communications company headquartered in Montreal, Quebec). From 2001 to 2004, Mr. Anderson was President of BCE Ventures and from 1997 to 2000 was Chief Financial Officer of BCE Inc. Mr. Anderson was formerly a director of Four Seasons Hotels Inc. and Sears Canada Inc.

Steven West

 Mr. Steven M. West is President, Chief Executive Officer, Non-Independent Director of Nordion Inc. He was appointed Chief Executive Officer in January 2010. Mr. West, who in September 2009 was appointed Chief Operating Officer, has served as President of Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President of DiverseyLever Canada. His background includes various Chief Executive Officer assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field. Steve has a degree in Genetics from London University (UK) and completed postgraduate research in Biotechnology. He is a member of the Canadian Council of Chief Executives and the Institute of Corporate Directors.

G. Peter Dans

 Mr. G. Peter Dans is Chief Financial Officer of Nordion Inc. Peter Dans joined Nordion Inc. Mr. Dans held the positions of SVP and VP Financial Planning and Analysis with Nordion from 2007 to 2010. Before that he worked at Nortel Networks and was CFO of LG-Nortel in Korea since 2005.

Grant Gardiner

 Mr. Grant Gardiner has been appointed as Senior Vice President, General Counsel, Corporate Secretary of Nordion Inc., effective January 28, 2013. Mr. Gardiner joins Nordion from Research in Motion Limited (RIM) where he currently serves as Vice-President, Associate General Counsel and acted as Corporate Secretary to RIM's Board of Directors for approximately four years. During his tenure at RIM, which began in 2008, Grant has advised on securities matters, mergers & acquisitions, ethics and compliance programs as well as Board and Corporate Governance matters. With leadership roles at other global, publicly-traded companies such as Cognos Inc. (now IBM) and JDS Uniphase, Mr. Gardiner's experience includes mergers and acquisitions, corporate governance, commercial transactions, as well as securities and anti-corruption law. He holds a Bachelor of Business Administration from the University of Prince Edward Island (1988), an L.L.B. from Osgoode Hall Law School (1991) and was admitted to the Ontario Bar in 1993.

Christopher Ashwood

 Mr. Christopher Ashwood is Senior Vice President - Corporate Services of Nordion Inc. Mr. Ashwood was Nordion’s SVP of Human Resources and Information Technology from 2008 to 2010. Prior to joining Nordion in 2008, he was Vice President, Product Development Solutions at Nortel Networks.

Jill Chitra

 Ms. Jill Chitra is Senior Vice President - Quality and Regulatory Affairs of Nordion Inc. Prior to 2010, Ms. Chitra was VP, Strategic Technologies. From 2006 to 2008, she was VP, Global Research & Development, and before that VP, Engineering & Development.

Tamra Benjamin

 Ms. Tamra Benjamin is Vice President - Public Affairs of Nordion Inc. Prior to her appointment, Ms. Benjamin was VP, Communications, Nordion. From 2006 to 2009, Ms. Benjamin worked in Communications roles. Prior to joining Nordion, Ms. Benjamin was Director, Marketing Communications with TenXc Wireless.

Tom Burnett

 Mr. Tom Burnett is General Manager - Medical Isotopes of Nordion Inc. Mr. Burnett joined Nordion in 2006 as the Global Marketing Director for Medical Isotopes, and subsequently held the position of VP, Global Sales prior to his appointment.

Scott McIntosh

 Mr. Scott McIntosh is Chief Operating Officer - Specialty Isotopes of Nordion Inc. Prior to his appointment, Mr. McIntosh was VP, Manufacturing with Nordion since 2005.

Jeffrey Brown

 Mr. Jeffrey J. Brown is Independent Director of Nordion Inc. Since 2007, Mr. Brown has been the Chief Executive Officer and founding member of Brown Equity Partners, LLC (a U.S. venture capital firm and private equity firm in Orange County, California). Previously he served as a founding partner for Forrest Binkley & Brown, a U.S. private equity/venture capital firm. Mr. Brown has served on the board of directors of over 40 companies during his 25 years in the investment industry.

William Dempsey

 Mr. William G. Dempsey is Independent Director of Nordion Inc. MrMr. Dempsey was an Executive with Abbott Laboratories (a health-care company) for 25 years prior to his retirement in 2007. Mr. Dempsey’s assignments included Executive Vice-President of the Pharmaceutical Products Group and Senior Vice-President of International Operations.

Mary Mogford

 Ms. Mary A. Mogford is Independent Director of Nordion Inc. Ms. Mogford is a Corporate Director and a former Deputy Minister of Finance and Deputy Minister of Natural Resources for the Province of Ontario. Ms. Mogford was made a Fellow of the Institute of Corporate Directors (ICD) in 2002 in recognition of her contribution to corporate governance in Canada and in 2004 she was one of the first directors accredited to the ICD/Rotman School of Management Directors Education Program. Ms. Mogford was formerly a director of Falconbridge Limited, Sears Canada and 9 other public company boards.

Sean Murphy

 Mr. Sean E. Murphy is Independent Director of Nordion Inc. Mr. Murphy joined Evercore Partners Inc., an independent investment banking advisory firm, in September 2011 as a Senior Advisor, Investment Banking. He previously served as Vice-President of Licensing and Business Development for Abbott Laboratories (a health-care company) for 10 years, prior to his retirement in 2010. During Mr. Murphy’s 30 years of service at Abbott, he also served as President of Perclose Inc., a company in the international vascular business, which was acquired by Abbott.

Kenneth Newport

 Mr. Kenneth E. Newport CA, CPA, is Independent Director of Nordion Inc. Mr. Newport served as Senior Vice-President and Executive Committee member at PRA International Inc. for three years until his retirement in 2005. In the mid-nineties he was co-founder and President of CroMedica Inc., a clinical trials contract research organization which was sold to PRA International in 2002. Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He is a member of the Institute of Corporate Directors (ICD.D) and serves on the corporate boards of Jennerex Inc., Medgenesis Therapeutics Inc. and The Ottawa Hospital Research Institute.

Adeoye Olukotun

 Dr. Adeoye Y. Olukotun, M.D., is Independent Director of Nordion Inc. Dr. Olukotun has been the Chief Executive Officer of Cardiovax Inc., a biotechnology company focused on developing innovative cardiovascular therapies, since 2006. He is also a co-founder of VIA Pharmaceuticals and served as its Chief Medical Officer from 2004 until 2008. From 2000 to 2003, he was the Chief Executive Officer of CR Strategies, LLC, a clinical research and development consulting firm. From 1996 to 2000, Dr. Olukotun was Vice President of Medical and Regulatory Affairs and Chief Medical Officer of Mallinckrodt, Inc. He is a Fellow of the American College of Cardiology as well as the American Heart Association. Dr. Olukotun was previously a director of Icagen Inc. and SemBioSys Genetic, Inc.

Janet Woodruff

 Ms. Janet P. Woodruff is Independent Director of Nordion Inc. Ms. Woodruff, a Chartered Accountant, is a Consultant and Corporate Director, having recently served as Vice-President and Special Advisor of BC Hydro until 2011, and as a director of Pacific Northern Gas Ltd. Prior to this, Ms. Woodruff served as Interim President (2009-10) and Vice-President and Chief Financial Officer (2007-08) of BC Transmission Corporation. Ms. Woodruff was Vice President and CFO of Vancouver Coastal Health (2003-07), following fourteen years with Westcoast Energy. Ms. Woodruff holds the Institute of Corporate Directors accreditation. Ms. Woodruff is a director of the Mutual Fund Dealers Association of Canada and a former director of Pacific Northern Gas.

Ana Raman

Insider Trading

» Full list on Insider Trading
Search Stocks